BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 28584158)

  • 1. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
    Zhang Y; Zhang J; Cui P; Zhang Y; Zhang W
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.
    Sheen P; Lozano K; Gilman RH; Valencia HJ; Loli S; Fuentes P; Grandjean L; Zimic M
    Tuberculosis (Edinb); 2013 Sep; 93(5):515-22. PubMed ID: 23867321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.
    Gopal P; Tasneen R; Yee M; Lanoix JP; Sarathy J; Rasic G; Li L; Dartois V; Nuermberger E; Dick T
    ACS Infect Dis; 2017 Jul; 3(7):492-501. PubMed ID: 28271875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide.
    Sun Z; Zhang Y
    Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
    BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
    Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH
    Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
    Zimic M; Fuentes P; Gilman RH; Gutiérrez AH; Kirwan D; Sheen P
    Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.
    Zhang Y; Scorpio A; Nikaido H; Sun Z
    J Bacteriol; 1999 Apr; 181(7):2044-9. PubMed ID: 10094680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-
    Werngren J; Alm E; Mansjö M
    J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis.
    Zimic M; Loli S; Gilman RH; Gutierrez A; Fuentes P; Cotrina M; Kirwan D; Sheen P
    Microb Drug Resist; 2012 Aug; 18(4):372-5. PubMed ID: 22372927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
    Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
    Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
    Rosen BC; Dillon NA; Peterson ND; Minato Y; Baughn AD
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
    Yüksel P; Tansel O
    New Microbiol; 2009 Apr; 32(2):153-8. PubMed ID: 19579692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis.
    Modlin SJ; Marbach T; Werngren J; Mansjö M; Hoffner SE; Valafar F
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis.
    Shi W; Zhang X; Jiang X; Yuan H; Lee JS; Barry CE; Wang H; Zhang W; Zhang Y
    Science; 2011 Sep; 333(6049):1630-2. PubMed ID: 21835980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
    Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y
    Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms.
    Sun Z; Scorpio A; Zhang Y
    Microbiology (Reading); 1997 Oct; 143 ( Pt 10)():3367-3373. PubMed ID: 9353938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
    Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
    J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of pyrazinamidase activity using a cell-free
    Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
    Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.
    Zhang Y; Permar S; Sun Z
    J Med Microbiol; 2002 Jan; 51(1):42-49. PubMed ID: 11800471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.